New Cellular Imaging Systems

Included is a suite of applications that assist the pathologist and oncologist in their review of key breast cancer IHC tests. The system is also designed to detect micrometastatic cancer cells that may be found in bone marrow and other clinical samples.

"We are responding to a rapidly increasing market demand for the automated analysis of protein and DNA probe tests,” said Carl Hull, CEO of Applied Imaging (Santa Clara, CA, USA), which developed Ariol. "External estimates indicate that gene-based testing is growing at 20-30% per year in major clinical laboratories.”




Related Links:
Applied Imaging